Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
3.540
-0.200 (-5.35%)
At close: Apr 1, 2025, 4:00 PM
3.685
+0.145 (4.09%)
After-hours: Apr 1, 2025, 4:48 PM EDT
Karyopharm Therapeutics Market Cap
Karyopharm Therapeutics has a market cap or net worth of $29.79 million as of April 1, 2025. Its market cap has decreased by -80.68% in one year.
Market Cap
29.79M
Enterprise Value
190.11M
1-Year Change
-80.68%
Ranking
Category
Stock Price
$3.54
Market Cap Chart
Since November 6, 2013, Karyopharm Therapeutics's market cap has decreased from $442.90M to $29.79M, a decrease of -93.27%. That is a compound annual growth rate of -21.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 31.50M | -62.81% |
| Dec 31, 2024 | 84.70M | -14.53% |
| Dec 29, 2023 | 99.10M | -64.08% |
| Dec 30, 2022 | 275.90M | -43.21% |
| Dec 31, 2021 | 485.80M | -57.36% |
| Dec 31, 2020 | 1.14B | -5.35% |
| Dec 31, 2019 | 1.20B | 111.62% |
| Dec 31, 2018 | 568.80M | 25.59% |
| Dec 29, 2017 | 452.90M | 16.82% |
| Dec 30, 2016 | 387.70M | -18.12% |
| Dec 31, 2015 | 473.50M | -61.32% |
| Dec 31, 2014 | 1.22B | 79.50% |
| Dec 31, 2013 | 681.90M | 53.96% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |